Vir Biotechnology Inc VIR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:17 PM EDT
43.98quote price arrow up+0.86 (+1.99%)
Volume
358,511
52 week range
25.31 - 141.01

...

Loading . . .
  • Open43.45
  • Day High45.67
  • Day Low43.14
  • Prev Close43.12
  • 52 Week High141.01
  • 52 Week High Date01/27/21
  • 52 Week Low25.31
  • 52 Week Low Date01/04/21

Key Stats

  • Market Cap5.629B
  • Shares Out127.98M
  • 10 Day Average Volume0.66M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change65.01

KEY STATS

  • Open43.45
  • Day High45.67
  • Day Low43.14
  • Prev Close43.12
  • 52 Week High141.01
  • 52 Week High Date01/27/21
  • 52 Week Low25.31
  • 52 Week Low Date01/04/21
  • Market Cap5.629B
  • Shares Out127.98M
  • 10 Day Average Volume0.66M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change65.01

RATIOS/PROFITABILITY

  • EPS (TTM)-2.49
  • P/E (TTM)-17.69
  • Fwd P/E (NTM)-33.14
  • EBITDA (MRQ)-291.538M
  • ROE (MRQ)-52.36%
  • Revenue (MRQ)76.37M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-391.09%
  • Debt To Equity (MRQ)0.13%

EVENTS

  • Earnings Date05/12/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Vir Biotechnology Inc

Profile

MORE
Vir Biotechnology, Inc. is a clinical-stage immunology company. The Company is focused on developing treatments to treat and prevent serious infectious diseases. Its technology platforms are focused on antibodies, T cells, innate immunity and small interfering ribonucleic acid (siRNA). Its pipeline consists of product candidates targeting hepatitis B virus (HBV), influenza A, human immunodeficiency virus (HIV) and tuberculosis (TB). Its product candidates include VIR-2218...
Vicki Sato Ph.D.
Chairman
George Scangos Ph.D.
President
Howard Horn
Chief Financial Officer
Michael Kamarck Ph.D.
Chief Technology Officer
Herbert Virgin IV
Executive Vice President
Address
499 Illinois St Ste 500
San Francisco, CA
94158-2521
United States

Top Peers

SYMBOLLASTCHG%CHG
ADPT
Adaptive Biotechnologies Corp
43.07+2.90+7.22%
ALLK
Allakos Inc
102.32-2.08-2.00%
KOD
Kodiak Sciences Inc
109.91+3.71+3.49%
PACB
Pacific Biosciences of California Inc
32.47+1.74+5.64%
NTLA
Intellia Therapeutics Inc
68.12-0.28-0.42%